Zai Lab grants share options and RSUs to employees

Zai Lab Limited, listed on the Main Board of the Stock Exchange (9688) and NASDAQ (ZLAB), granted 6,600 share options (in ADSs) to two employee participants on September 8, 2025. The exercise price for these options is $31.7 per ADS. Concurrently, the company also awarded 9,893 restricted share units (in ADSs) to four employee participants. The options and units are designed to vest 25% annually over four years, contingent on continued employment.

These grants recognize and reward employee contributions, providing additional incentives to foster the group’s continued success. The grants are not subject to performance targets or clawback mechanisms, aligning with the compensation committee's view of market competitiveness and customary practice.

As of the grant date, 80,729,173 shares remain available for future grants under the 2024 equity incentive plan’s scheme mandate limit. The maximum number of shares that may be delivered under the plan is 99,208,743.